Summary
Allison Creason is a Group Lead in Computational Precision Oncology at OHSU with over a decade of experience applying machine learning and multi-omics analyses to translate complex cancer biology into clinically actionable insights. She leads a multidisciplinary team developing scalable, reproducible ML/AI pipelines for histopathology, spatial omics, and sequencing data鈥攚ork that has been adopted across cancer centers and integrated into CLIA/CAP clinical workflows. As HTAN Data Science co-Lead and Co-Investigator on multiple NCI grants, she shapes data strategy for large consortia while championing FAIR principles and community benchmarking. Her technical breadth spans bulk and single-cell genomics, proteomics, multiplexed tissue imaging, and workflow engineering with Galaxy, Nextflow, and CWL. Notably, she has bridged research and diagnostic practice by implementing ACMG-compliant variant interpretation pipelines and driving multi-modal biomarker validation in clinical trials.
10 years of coding experience
6 years of employment as a software developer
Doctor of Philosophy (PhD), Molecular and Cellular Biology, Doctor of Philosophy (PhD), Molecular and Cellular Biology at Oregon State University